Company Filing History:
Years Active: 2017-2020
Title: Innovations of Inventor Wen-Wei Lin
Introduction
Wen-Wei Lin is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of important compounds. With a total of five patents to his name, Lin's work has the potential to impact drug formulation and delivery.
Latest Patents
One of Lin's latest patents is for a crystalline form of olaparib, which is a drug used in cancer treatment. This invention provides a novel crystalline form of olaparib, characterized by a specific process for its preparation. The process involves forming a solution of crude olaparib and an organic solvent, followed by the addition of an anti-solvent to create a slurry. The precipitate is then isolated and dried to obtain a crystalline form III of olaparib. Another significant patent involves the crystalline forms of lifitegrast, which are characterized by distinct powder X-ray diffraction patterns. These forms, S1 and S2, have specific peaks that can be utilized in their identification and characterization.
Career Highlights
Wen-Wei Lin has worked with reputable companies in the pharmaceutical industry, including Scinopharm Taiwan Ltd. and Scintopharm Taiwan Ltd. His experience in these organizations has contributed to his expertise in drug formulation and patent development.
Collaborations
Lin has collaborated with notable colleagues such as Tsung-Cheng Hu and Kuan-Hsun Wang. Their combined efforts in research and development have led to advancements in the pharmaceutical field.
Conclusion
Wen-Wei Lin's innovative work in the development of crystalline forms of pharmaceutical compounds showcases his significant contributions to the industry. His patents not only reflect his expertise but also hold promise for future advancements in drug formulation.